COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the newly added workshop of the pharmaceutical production license of the
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Industry Bulletin No.: 2013-046
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the addition of new workshops for pharmaceutical production licenses of wholly-owned subsidiaries
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
On December 10, 2013, Jilin Cao Dandan Pharmaceutical Co., Ltd. (hereinafter referred to as: Cao Huandan Pharmaceutical Co., Ltd.), a wholly-owned subsidiary of the company, obtained the Pharmaceutical Production License of Cao Youdan Pharmaceuticals by the Jilin Food and Drug Administration. Added permission for the workshop. Cao Dandan Pharmaceutical "Pharmaceutical Production License" Production Address and Production Range: Industrial Zone, Dunhua Economic Development Zone No. 9: Mixture, Soft Capsule, Wine, Syrup, Ointment ***
The production address and production scope of the newly added workshop of the drug production license of Cao Dandan Pharmaceutical: No. 999, Hongda Road, Dunhua Economic Development Zone, Jilin Province: mixture, soft capsule, wine, syrup, ointment.
The workshop is the address of the ginseng product serialization project (Dunhua Plant). The new workshop of Cao Dandan Pharmaceutical Co., Ltd. can obtain the drug GMP certification before it can produce and sell drugs.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
December 11, 2013